Our Diverse Portfolio of Ventures From PCD to Generic, Comprehensively Meeting Healthcare Needs
The division is recognized for its leadership with the flagship brands link Cribol-Forte, Pantogen Inj. Gencobal Plus, Ncef 1g /1.5g Inj, Miki-500 Inj, Matiz Inj, Nzone 1.5g Inj
Read More
Our Generics business in India has contributed excellent for the domestic pharmaceutical revenues with 1,500+ partners covering the entire country. The business operates
Read More
We continue to build our future pipeline of complex products with our established robust portfolio selection process, providing early launch capabilities along with
Read More